Granulocyte transfusion therapy: Update on potential clinical applications

Current Opinion in Hematology

Volumn 8, Issue 3, 2001, Pages 161-164

  Hübel, Kai ^a,b   Dale, David C ^a   Liles, W Conrad ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

BACTERIAL INFECTION; DONOR; GRANULOCYTE; GRANULOCYTE TRANSFUSION; HUMAN; LEUKAPHERESIS; MYCOSIS; NEUTROPHIL; PRIORITY JOURNAL; REVIEW;

GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTES; HUMANS; LEUKAPHERESIS; LEUKOCYTE TRANSFUSION; NEUTROPHILS;

EID: 0035043819     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200105000-00006     Document Type: Review

References (34)

1. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lung cancer
2. Recombinant granulocyte colony-stimulating factor reduces the infectious complications of cytotoxic chemotherapy
3. A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation
4. Renewed interest in granulocyte transfusion therapy
5. A prospective randomized trial of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in adults
6. Current approach to the management of neutropenia
7. Comparison of agents producing a neutrophilic leukocytosis in man: Hydrocortisone, prednisone, endotoxin and etiocholanolone
8. Rebirth of granulocyte transfusions: Should it involve pediatric oncology and transplant patients?
9. The use of G-CSF in normal neutrophil donors
10. A comparative trial of granulocyte-colony-stimulating-factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers
11. Effects of granulocyte-colony-stimulating factor on potential normal granulocyte donors
12. Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation
13. Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation
14. Combined administration of G-CSF and dexamethasone for the mobilization of granulocytes in normal donors: Optimization of dosing
15. Return of granulocyte transfusions
16. Blood counts in healthy donors 1 year after the collection of granulocyte-colony-stimulating factor-mobilized progenitor cells and the results of a second mobilization and collection
17. An examination of ethical issues raised in the pretreatment of normal volunteer granulocyte donors with granulocyte colony-stimulating factor
18. Blood kinetics and in vivo chemotaxis of transfused neutrophils: Effect of collection method, donor corticosteroid treatment, and short-term storage
19. In vitro function and post transfusion survival of granulocytes collected by continuous-flow centrifugation and by filtration leukapheresis
20. Granulocyte transfusion therapy in patients with malignancy
21. Functional characteristics of neutrophils collected and stored after administration of G-CSF
22. Storage of G-CSF-mobilized granulocyte concentrates
23. Preservation of function in granulocyte concentrates collected from donors stimulated with G-CSF/dexamethasone during storage at reduced temperature
24. Clinical perspectives of granulocyte transfusions: Efficacy to date
25. Leukocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients
26. Randomized trial of granulocyte transfusions versus intravenous immune globulin therapy for neonatal neutropenia and sepsis
27. Granulocyte transfusions
28. The pathology of transfusion-related acute lung injury
29. Life-threatening paroxysmal supraventricular tachycardia developed during granulocyte transfusion therapy for neutropenia-related infection
30. International forum -Granulocyte transfusions
31. Neutrophil transfusion for treatment of infections
32. Fatal graft-versus-host disease in a patient with lymphoblastic leukemia following normal granulocyte transfusion
33. Granulocyte transfusion in neutropenic patients
34. Granulocyte transfusion therapy